Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase
Jan 28, 2021
Upcoming Events
Email Alerts
Stay informed and receive company updates straight to your inbox.
Stock Information
Company Overview
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.
Investor Contact Information
Company
Ocuphire Pharma, Inc.
37000 Grand River Ave., Suite 120
Farmington Hills, MI 48335
T: 248-681-9815
ir@ocuphire.com
Investor Relations
LifeSci Advisors
250 West 55th Street, Suite 3401
New York, NY 10019
T: 646-889-1200
cdavis@lifesciadvisors.com
Transfer Agent
Olde Monmouth Stock Transfer Co., Inc.
200 Memorial Parkway
Atlantic Highlands, NJ 07716
T: 732-872-2727